Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Menstruation: choosing whether...and when.

A M Kaunitz1

  • 1University of Florida Health Science Center, Jacksonville, FL 32557, USA. andrew.kaunitz@jax.ufl.edu

Contraception
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms.

Climacteric : the journal of the International Menopause Society·2019
Same author

Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour.

BJOG : an international journal of obstetrics and gynaecology·2014
Same author

Management of pain associated with the insertion of intrauterine contraceptives.

Human reproduction update·2013
Same author

Contraceptive efficacy and safety of DMPA-SC.

Contraception·2004
Same author

Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2003
Same journal

Previous caesarean section and major complications during surgical abortion: a national multicentre case-control study.

Contraception·2026
Same journal

Quantification of residual levonorgestrel following extended use of the levonorgestrel 52 mg intrauterine device beyond 8 years.

Contraception·2026
Same journal

Mifepristone Provision Following Policy Shifts in 2022 & 2023.

Contraception·2026
Same journal

Bleeding Experience with Medication Abortion Prior to Embryonic Cardiac Activity.

Contraception·2026
Same journal

Importance of abortion training to residency program applicants: A national survey of OBGYN residents.

Contraception·2026
Same journal

Racial and Demographic Trends in Abortion Method Selection in Minnesota Among in-State Patients at or under 11 Weeks Gestational Duration, 2021-2024.

Contraception·2026
See all related articles

Reducing menstrual frequency offers significant health benefits for women, especially those with disorders or conditions aggravated by menses. New oral contraceptive (OC) formulations aim to decrease bleeding to four times annually, improving quality of life.

Area of Science:

  • Reproductive Health
  • Gynecology
  • Pharmacology

Background:

  • Menstruation poses significant health concerns for many women due to disorders and associated conditions.
  • Modern women menstruate more frequently than in ancestral societies, potentially increasing health risks.
  • Conventional oral contraceptives (OCs) offer limited relief for menstrual disorders.

Purpose of the Study:

  • To evaluate alternative oral contraceptive (OC) regimens for reducing menstrual frequency.
  • To investigate a new OC formulation designed to decrease menstrual bleeding to four times per year.

Main Methods:

  • Review of existing literature on oral contraceptive efficacy for menstrual disorders.
  • Investigation of a novel OC formulation targeting reduced menstrual frequency.

Related Experiment Videos

Main Results:

  • A new OC formulation is under investigation to reduce menstrual bleeding to four times annually.
  • Reduced menstrual frequency is generally welcomed by women, including the possibility of amenorrhea.

Conclusions:

  • Less frequent menstruation, including amenorrhea, is desirable for many women.
  • Reduced menstrual frequency benefits women with medical conditions aggravated by menses, military personnel, athletes, and adolescents.